BioSpace News Archive

FDA

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Breakthrough Therapy Designation from FDA

For LENVIMA plus KEYTRUDA Combination Treatment as Potential First-Line Treatment of Patients with Advanced Unresectable Hepatocellular Carcinoma Not Amenable to Locoregional Treatment

July 23, 2019
·
4 min read
Business

Medidata Reports Second Quarter 2019 Results

Medidata announced its financial results for the second quarter of 2019.

July 23, 2019
·
7 min read
Huge CPhI & P-MEC China a direct result of surging manufacturing

Great Hall of China: Informa adds additional capacity to Asia’s largest pharma event with record 66,000+ visits from 141 countries

July 23, 2019
·
3 min read
Biotech Beach

Abzena Announces Successful Technical Transfer of Synaffix GlycoConnect™ Antibody Drug Conjugate (ADC) Technology to Enable Use in Client Projects

Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect™ and HydraSpace™.

July 23, 2019
·
1 min read
Business

Gain Therapeutics SA Announces Award Notification of a €1.4M Grant Support From Eurostars-2 Together With the Institute for Research in Biomedicine and Neuro-Sys SAS After Having Scored 2nd Among 325 Eligible Applications

Gain Therapeutics SA announced that together with Dr. Maurizio Molinari from the Institute for Research in Biomedicine, Bellinzona (Switzerland) affiliated to the Università della Svizzera italiana (USI) and Neuro-Sys SAS in Gardanne (France), it has received funding support from Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and Innosuisse – Swiss Innovation Agency.

July 23, 2019
·
4 min read
Policy

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

North America, Europe and Japan trial seeks approval for the US and Japanese markets

July 23, 2019
·
3 min read
BioForest

LifeSpan BioSciences Releases Best-In-Class PathPlus™ Top Performing Immunohistochemistry Antibodies for Cancer Targets

LifeSpan BioSciences, Inc., the industry leader in molecular pathology, announced the first release of its PathPlus™ series of antibodies.

July 23, 2019
·
3 min read
Policy

Akebia Therapeutics Announces Submission of Vadadustat New Drug Application in Japan for Anemia Due to Chronic Kidney Disease by Collaboration Partner, MTPC

JNDA Submission Represents First Regulatory Submission for Marketing Approval of Vadadustat

July 23, 2019
·
6 min read
Global Surgical Cutting Devices Market 2019-2023 | 5% CAGR Projection Over the Next Five Years | Technavio

The global surgical cutting devices market is expected to post a CAGR of close to 5% during the period 2019-2023, according to the latest market research report by Technavio.

July 23, 2019
·
4 min read
Deals

Key Surgical Signs Agreement To Acquire Insitumed

Global Provider Continues to Expand Product Portfolio

July 23, 2019
·
2 min read